Buscar resultados de ensayos clínicos
Hemolysis - 26 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty Condición: Hemolysis Fecha: 2008-11-17 Intervenciones: Drug: Propofol Patients in the Propofol Group (PG) will be induced with target-controlled infusion (TCI) |
Completed |
Nombre del estudio: Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood Sampling Condición: Hemolysis Fecha: 2015-11-24 Intervenciones:
|
Recruiting |
Nombre del estudio: Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department. Condición:
Fecha: 2016-11-24 Intervenciones: Device: Hemolysis Point-of-Care test Hemolysis measurement of plasma using a point of care test to deter |
Completed |
Nombre del estudio: Isoagglutinins in the Development of IVIG-associated Hemolysis Condición:
Fecha: 2014-08-29 |
Completed |
Nombre del estudio: Hemolysis in Patients With Hereditary Spherocytosis (HS) Condición:
Fecha: 2010-09-12 Intervenciones: Other: fermented papaya preparation (FPP) Hemolysis will be assayed by suspending 3 ml of packed RBC in |
Not yet recruiting |
Nombre del estudio: Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease Condición: Haemolysis Neonatal Fecha: 2017-04-24 Intervenciones: Drug: intravenous immunoglobulin giving intravenous immunoglobulin to neonates included in inclusion cri |
Completed |
Nombre del estudio: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome Condición: Atypical Hemolytic-Uremic Syndrome Fecha: 2010-08-31 Intervenciones: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Nombre del estudio: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome Condición: Atypical Hemolytic-Uremic Syndrome Fecha: 2010-08-31 Intervenciones: Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient |
Recruiting |
Nombre del estudio: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) Condición: Warm Antibody Autoimmune Hemolytic Anemia Fecha: 2015-11-19 Intervenciones: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti |
Recruiting |
Nombre del estudio: R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions Condición: Hemolysis Fecha: 2012-03-16 |